Association between aspirin use and the prevalence of nonalcoholic fatty liver disease: a cross-sectional study from the Third National Health and Nutrition Examination Survey

Prevalence of Nonalcoholic Fatty Liver Disease in the United States: The Third National Health and Nutrition Examination Survey, 1988–1994

(2013) Mariana Lazo et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Aspirin in type 2 diabetes, a randomised controlled study: effect of different doses on inflammation, oxidative stress, insulin resistance and endothelial function

(2013) R. P. Raghavan et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

(2012) Naga Chalasani et al.   HEPATOLOGY

Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults

(2011) G. Vernon et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Nitro-aspirin is a potential therapy for non alcoholic fatty liver disease

(2011) Mohamed Ibrahim et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Determinants of Aspirin Metabolism in Healthy Men and Women: Effects of Dietary Inducers of UDP-Glucuronosyltransferases

(2011) Sandi L. Navarro et al.   Journal of Nutrigenetics and Nutrigenomics

JNKs, insulin resistance and inflammation: A possible link between NAFLD and coronary artery disease

(2011) Giovanni Tarantino   WORLD JOURNAL OF GASTROENTEROLOGY

Components of metabolic syndrome are independent predictors of mortality in patients with chronic liver disease: a population-based study

(2010) M. Stepanova et al.   GUT

Effectiveness of antiplatelet drugs against experimental non-alcoholic fatty liver disease

(2008) K Fujita et al.   GUT